Yun Xia Xin
Vermogen: 571 390 $ op 31-08-2026
Vermogen: 571 390 $ op 31-08-2026
Ms. Yun Xia Xin is an Executive Director at China Shineway Pharmaceutical Group Ltd. and a Chairman at Shineway Medical Science & Technology (Lang Fang) Co., Ltd. She is on the Board of Directors at China Shineway Pharmaceutical Group Ltd. She received her MBA from Yangtze University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2025 | 540.000 ( 0,07% ) | 571 390 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED | Oprichter | 14-08-2002 |
Shineway Medical Science & Technology (Lang Fang) Co., Ltd.
Shineway Medical Science & Technology (Lang Fang) Co., Ltd. Financial ConglomeratesFinance Engages in the investment and property holding businesses | Voorzitter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
China Shineway Pharmaceutical Group Ltd.
China Shineway Pharmaceutical Group Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets modern Chinese pharmaceutical products | Health Technology |
Shineway Medical Science & Technology (Lang Fang) Co., Ltd.
Shineway Medical Science & Technology (Lang Fang) Co., Ltd. Financial ConglomeratesFinance Engages in the investment and property holding businesses | Finance |
Yangtze University
Yangtze University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau